Navigation Links
Bend Research Announces Schedule of Events at 2011 AAPS Annual Meeting and Exposition
Date:10/18/2011

BEND, Ore., Oct. 18, 2011 /PRNewswire/ -- Bend Research Inc. (www.bendresearch.com), a leading independent drug-formulation development and manufacturing company, has announced a full schedule of events at the 2011 annual meeting and exposition of the American Association of Pharmaceutical Scientists (AAPS) in Washington, D.C.

"Bend Research's business model has changed significantly over the last few years and we are now working with more than 70 clients," said Jim Nightingale, President of Bend Research. "Many people are interested in that evolution and we're eager to talk with them about what it means in terms of partnership opportunities. But we also want to emphasize the things that haven't changed: our focus is still on offering the scientific and engineering excellence that has made us a leader in developing drug-delivery technologies. Examples of that work are what we are sharing at AAPS this year."

The company will host two colloquiums, both at the Walter E. Washington Convention Center. The first, titled "Development and Robust Manufacturing of a Dry Powder Intranasal Vaccine against Norovirus," will be at 1:00 p.m. Oct. 24 in Room 158. It will feature guests from Bend Research, LigoCyte Pharmaceuticals and Lovelace Respiratory Research Institute.

"We are excited to present these novel results, which highlight a great collaboration," said Nightingale.

The second colloquium, titled "Amorphous Spray-Dried Dispersion Process Scale-Up and Quality by Design," will be at 2:00 p.m. Oct. 25 in Room 156. It will feature speakers from Bend Research, Vertex Pharmaceuticals, Bristol-Myers Squibb, and Hovione.

Space in each colloquium is limited to 60 people and guests are requested to register in advance at bendresearch.com/content/2011-aaps-annual-meeting-exposition.

In addition, Bend Research will be presenting the following eight posters at the annual meeting.

Bend Research Announces 2011 AAPS Schedule

  • "An Automated, Aseptic Sampling System for Improved Bioreactor Process Control," by Adam Carroll and David Newbold from 8 a.m. to noon Oct. 26 (Poster W4386)

  • "An Inhalable Formulation of Nanocrystalline Camptothecin for the Treatment of Lung Cancer," by Jeff Breit and David Vodak from 8 a.m. to noon Oct. 27 (Poster R6075)

  • "Amorphous Spray-Dried Dispersion (SDD) Formulation Screening," by Rod Ketner and Doug Lorenz from 1 to 5 p.m. Oct. 26 (Poster W5239)

  • "Surface Characterization of Compound X and HPMCAS Spray-Dried Dispersion Particles," by David Vodak, David Lyon, and Dwayne Friesen from 1 to 5 p.m. Oct. 26 (Poster W5265)

  • "In Vitro Performance of Spray-Dried Dispersions of Low-Solubility Drugs Using Several Dispersion Polymers," by Mike Morgen, Brice Murri, Rory Morgan, and Travis Ringo from 1 to 5 p.m. Oct. 26 (Poster W5251)

  • "Nanoparticles for Improved Local Retention After Intraarticular Injection into the Knee," by Mike Morgen and Warren Miller from 8 a.m. to noon Oct. 26 (Poster W4155)

  • "Spray-Dried Dispersion Formulation for Oral Solubilization of a Low-Solubility Histone Deacetylase Inhibitor," by Corey Bloom, Tom Whitehead, Fred Jordan, and Steve Shuttleworth from 1 to 5 p.m. Oct. 26 (Poster W5221)

  • "Development and Validation of a Wet Particle Size Method for a Water-Soluble Jet-Milled Active Pharmaceutical Ingredient," by Judson King (developed with Transcept) from 1 to 5 p.m. Oct. 26 (Poster W5340)

Bend Research will be at Booth 1813 in the convention center exhibit hall, where it will host its traditional "Booth Bar" happy hours from 3:00 to 5:30 p.m. Oct. 24 and from 4 to 6:30 p.m. Oct. 25.

"I'm very proud of what we are sharing at AAPS," said Nightingale. "It shows the high-caliber work that any client can expect from Bend Research."

About Bend Research Inc.

For more than 35 years, Bend Research has worked with clients to create value to solve their most difficult scientific and technical problems and advance new medicines that improve human health. This success is based on the company's ability to develop, advance, and commercialize pharmaceutical technologies, grown from a solid base of scientific and engineering fundamental understanding.

Bend Research advances promising drug candidates from conception through commercialization by providing formulation and dosage-form support, assisting in process development and optimization, and manufacturing clinical-trial quantities of drug candidates in its cGMP facilities. Bend Research is a leader in novel formulations, including solubilization technologies such as spray-dried dispersions and hot-melt extrusion formulations, as well as controlled-release, inhalation, and biotherapeutics technologies.

The company has more than 240 employees based in four state-of-the-art facilities in Bend, Oregon, USA.


'/>"/>
SOURCE Bend Research Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. VisionSpring Research Finds Seeing to be the Most Important of Five Senses
2. Techstreet and the ISPE Extend Partnership to Expedite Drug Research with Subscription Offering for Life Science Engineers
3. Elsevier Offers 950 New Health Titles to Research4Life
4. PAREXEL and National University of Singapore Establish Program in Singapore to Meet Increasing Demand in Asia for Clinical Research Talent
5. New Research Shows Chronic Pain is not Being Adequately Measured[1]
6. New Research Shows PET Imaging Effective in Predicting Lung Cancer Outcomes
7. Inovio Pharmaceuticals Synthetic Vaccine for Cancer Recognized as Most Promising Research at Global Vaccine Congress
8. Research Presented at The Obesity Society Meeting Shows Link Between BMI and Sleep Patterns
9. OncoMed Pharmaceuticals Names Dr. Jakob Dupont VP Clinical Research
10. Adeonas Planned Clinical Trial of Proprietary Zinc-Based Therapy in Lou Gehrigs Disease is Hot Topic at 2011 California ALS Research Summit
11. St. Jude Childrens Research Hospital Discovery Aided Quest for Adult Cancer Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... , March 24, 2017 ... to develop sutezolid as effective response to infectious disease ... Alliance and the Medicines Patent Pool (MPP) announced a ... antibiotic drug candidate which demonstrated encouraging results in early ... in combination with other TB drugs and follows the ...
(Date:3/23/2017)... , March 23, 2017 The ... ageing population, increasing diabetic population, accelerating economic growth and increasing ... this industry are higher life expectancy of ESRD patients, rising ... emerging markets. However, the expansion of the market is hindered ... ...
(Date:3/23/2017)... and INDIANAPOLIS , March ... LLY ) and the William Sansum Diabetes Center ... of Latino people affected by diabetes through enhanced research, ... of diabetes and cardiovascular disease bears a disproportionate weight ... ," said David Kerr , M.D., FRCPE, ...
Breaking Medicine Technology:
(Date:3/24/2017)... Maryland (PRWEB) , ... March 24, 2017 , ... ... is the first Certified Medical Reiki™ Master in Frederick, MD. Judy says, “I ... their caregivers during what is often a very difficult and challenging time.” , ...
(Date:3/24/2017)... ... March 24, 2017 , ... “The Adventures of Joey, The ... silly dog who lives his life to the fullest, as God intended. “The Adventures ... Patti Holmgren, a mother and grandmother pursuing her passion for writing, especially about truth ...
(Date:3/23/2017)... ... 23, 2017 , ... Texas Physical Therapy Specialists (TexPTS) is pleased to ... 2. The clinic is the group’s second in New Braunfels and 22nd in Texas. ... New Braunfels location brings things full circle for the group, “It’s crazy to think ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... serving the families and businesses of the Norwalk and Vermillion areas, celebrates ... Recovery Center (N.O.R.A.) is a nonprofit, community-based substance abuse prevention and peer ...
(Date:3/23/2017)... ... March 23, 2017 , ... The Wound Certification Prep ... Communications Holdings, LLC, today announced that RestorixHealth® has officially endorsed WCPC ... centers interested in becoming Certified Wound Specialist Physicians (CWSP®). , This collaborative ...
Breaking Medicine News(10 mins):